Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 196

1.

Quality of life three years after diagnosis of localised prostate cancer: population based cohort study.

Smith DP, King MT, Egger S, Berry MP, Stricker PD, Cozzi P, Ward J, O'Connell DL, Armstrong BK.

BMJ. 2009 Nov 27;339:b4817. doi: 10.1136/bmj.b4817.

2.

Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study.

Potosky AL, Davis WW, Hoffman RM, Stanford JL, Stephenson RA, Penson DF, Harlan LC.

J Natl Cancer Inst. 2004 Sep 15;96(18):1358-67.

3.

A national study of adverse effects and global quality of life among candidates for curative treatment for prostate cancer.

Kyrdalen AE, Dahl AA, Hernes E, Småstuen MC, Fosså SD.

BJU Int. 2013 Feb;111(2):221-32. doi: 10.1111/j.1464-410X.2012.11198.x. Epub 2012 Jun 6.

4.

The effect of androgen deprivation therapy on health-related quality of life in men with prostate cancer.

Lubeck DP, Grossfeld GD, Carroll PR.

Urology. 2001 Aug;58(2 Suppl 1):94-100. Review.

PMID:
11502459
5.

Quality of life after treatment for localized prostate cancer: differences based on treatment modality.

Davis JW, Kuban DA, Lynch DF, Schellhammer PF.

J Urol. 2001 Sep;166(3):947-52.

PMID:
11490252
7.
8.

Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study.

Potosky AL, Legler J, Albertsen PC, Stanford JL, Gilliland FD, Hamilton AS, Eley JW, Stephenson RA, Harlan LC.

J Natl Cancer Inst. 2000 Oct 4;92(19):1582-92.

9.

Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer.

Wei JT, Dunn RL, Sandler HM, McLaughlin PW, Montie JE, Litwin MS, Nyquist L, Sanda MG.

J Clin Oncol. 2002 Jan 15;20(2):557-66.

PMID:
11786586
10.

Long-term health-related quality of life after primary treatment for localized prostate cancer: results from the CaPSURE registry.

Punnen S, Cowan JE, Chan JM, Carroll PR, Cooperberg MR.

Eur Urol. 2015 Oct;68(4):600-8. doi: 10.1016/j.eururo.2014.08.074. Epub 2014 Sep 18.

PMID:
25242555
11.

Quality of life two years after radical prostatectomy, prostate brachytherapy or external beam radiotherapy for clinically localised prostate cancer: the Catalan Institute of Oncology/Bellvitge Hospital experience.

Guedea F, Ferrer M, Pera J, Aguiló F, Boladeras A, Suárez JF, Cunillera O, Ferrer F, Pardo Y, Martínez E, Ventura M.

Clin Transl Oncol. 2009 Jul;11(7):470-8.

PMID:
19574206
12.
13.

Quality of life and treatment outcomes: prostate carcinoma patients' perspectives after prostatectomy or radiation therapy.

Shrader-Bogen CL, Kjellberg JL, McPherson CP, Murray CL.

Cancer. 1997 May 15;79(10):1977-86.

PMID:
9149026
14.

Quality of life outcomes after brachytherapy for early stage prostate cancer.

Brandeis JM, Litwin MS, Burnison CM, Reiter RE.

J Urol. 2000 Mar;163(3):851-7.

PMID:
10687991
16.

Cardiovascular comorbidity and treatment regret in men with recurrent prostate cancer.

Nguyen PL, Chen MH, Hoffman KE, Chen RC, Hu JC, Bennett CL, Kattan MW, Sartor O, Stein K, D'Amico AV.

BJU Int. 2012 Jul;110(2):201-5. doi: 10.1111/j.1464-410X.2011.10709.x. Epub 2011 Nov 15.

17.

Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy.

Lilleby W, Fosså SD, Waehre HR, Olsen DR.

Int J Radiat Oncol Biol Phys. 1999 Mar 1;43(4):735-43.

PMID:
10098428
18.

Quality-of-life outcomes for men with prostate carcinoma detected by screening.

Smith DS, Carvalhal GF, Schneider K, Krygiel J, Yan Y, Catalona WJ.

Cancer. 2000 Mar 15;88(6):1454-63.

PMID:
10717630
19.

Factors associated with treatment received by men diagnosed with prostate cancer in Queensland, Australia.

Baade PD, Youlden DR, Gardiner RA, Ferguson M, Aitken JF, Yaxley J, Chambers SK.

BJU Int. 2012 Dec;110(11 Pt B):E712-9. doi: 10.1111/j.1464-410X.2012.011533.x. Epub 2012 Sep 27.

20.

The effect of high dose rate brachytherapy in combination with external beam radiotherapy on men's health-related quality of life and sexual function over a 2 year time span.

Conaglen HM, de Jong D, Hartopeanu C, Conaglen JV, Tyrie LK.

Clin Oncol (R Coll Radiol). 2013 Mar;25(3):197-204. doi: 10.1016/j.clon.2012.10.012. Epub 2012 Nov 22.

PMID:
23183305
Items per page

Supplemental Content

Write to the Help Desk